XERS - Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.02 revenue of $40.64M misses by $1.17M
2024-05-09 07:16:01 ET
More on Xeris Pharmaceuticals
- Xeris Biopharma: Checking-In On One Of My 'Top Ideas'
- Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript
- Xeris Pharmaceuticals Q1 2024 Earnings Preview
- Xeris gains as Oppenheimer highlights drug technology
- Seeking Alpha’s Quant Rating on Xeris Pharmaceuticals